Changes of Crohn’s disease phenotype over time

##plugins.themes.academic_pro.article.sidebar##

Published Nov 24, 2016
Download
pdf
Vol. 94 No. 6 (2016): Issue Jun 2016

##plugins.themes.academic_pro.article.main##

Afef Ouaz
Monia Fekih
Asma Labidi
Nadia Ben Mustapha
Meriem Serghini
Lilia Zouiten
Jalel Boubaker
Azza Filali

Abstract

Abstract :
 Introduction: Crohn's disease is a clinically heterogeneous condition. Our aim was to identify the phenotype evolution of Crohn’s disease over time according to the Montreal Classification and to precise predictive factors of the need for immunosuppressant treatment or surgery.
Methods: We included Crohn’s disease patients who were followed up for at least 5 years. We excluded patients who were lost to follow up before five. Patients were classified according to the Montreal classification for phenotype at diagnosis and five years later. The evolution of phenotype over time and the need for surgery, immunosuppressive or immunomodulatory drugs were evaluated.
Results: One hundred twenty consecutive patients were recruited: 70 males and 50 females. At diagnosis, 68% of patients belong to A2 as determined by the Montreal classification. Disease was most often localized in the colon. The disease location in Crohn’s disease remains relatively stable over time, with 93.4% of patients showing no change in disease location. Crohn’s disease phenotype changed during follow up, with an increase in stricturing and penetrating phenotypes from 6% to 11% after 5 years. The only predictive factor of phenotype change was the small bowel involvement (OR=3.7 [1.2-7.6]). During follow-up, 82% of patients have presented a severe disease as attested by the use of immunosuppressive drugs or surgery. The factors associated with the disease severity were: small bowel involvement (L1), the stricturing (B2) and penetrating (B3) phenotypes and perineal lesions            (OR=17.3 [8.4-19.7]; 12 [7.6-17.2]; 3[1.7-8.3] and 2.8 [2.2–5.1] respectively), without association with age, sex or smoking habits.
Conclusion:
Crohn's disease evolves over time: inflammatory diseases progress to more aggressive stricturing and penetrating phenotypes. The ileal location, the stricturing and penetrating forms and perineal lesions were predictive of surgery and immunosuppressant or immunomodulatory treatment.

Keywords:

Crohn's disease; phenotype; evolution

##plugins.themes.academic_pro.article.details##

References

  1. Satsangi J, Silverberg MS, Vermeire S, Colombel JF. The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications. Gut. 2006;55:749-53.
  2. Tarrant KM, Barclay ML, Frampton CM, Gearry RB. Perianal disease predicts changes in Crohn's disease phenotype-results of a populationbased study of inflammatory bowel disease phenotype. Am J Gastroenterol. 2008;103:3082-93.
  3. Louis E, Collard A, Oger AF, Degroote E, Aboul Nasr El Yafi FA, Belaiche J. Behaviour of Crohn's disease according to the Vienna classification: changing pattern over the course of the disease. Gut. 2001;49:777-82.
  4. Freeman HJ. Comparison of longstanding pediatric-onset and adult-onset Crohn's disease. J Pediatr Gastroenterol Nutr. 2004;39:183-6.
  5. Freeman HJ. Long-term prognosis of early-onset Crohn's disease diagnosed in childhood or adolescence. Can J Gastroenterol. 2004;18:661-5.
  6. Freeman HJ. Long-term natural history of Crohn's disease. World J Gastroenterol. 2009;15:1315-8.
  7. Magro F, Portela F, Lago P, Ramos de Deus J, Vieira A, Peixe P, et al. Crohn's disease in a southern European country: Montreal classification and clinical activity. Inflamm Bowel Dis. 2009;15:1343-50.
  8. Peyrin-Biroulet L, Harmsen WS, Tremaine WJ, Zinsmeister AR, Sandborn WJ, Loftus EV. Surgery in a population-based cohort of Crohn's disease from Olmsted County, Minnesota (1970-2004). Am J Gastroenterol. 2012;107:1693-701.
  9. Loftus EV, Schoenfeld P, Sandborn WJ. The epidemiology and natural history of Crohn's disease in population-based patient cohorts from North America: a systematic review. Aliment Pharmacol Ther. 2002;16:51-60.
  10. Romberg-Camps MJ, Dagnelie PC, Kester AD, Hesselink-van de Kruijs MA, Cilissen M, Engels LG, et al. Influence of phenotype at diagnosis and of other potential prognostic factors on the course of inflammatory bowel disease. Am J Gastroenterol. 2009;104:371-83.